THIS IS AN ONLINE E LOG BOOK TO DISCUSS OUR PATIENT'S DEIDENTIFIED HEALTH DATA SHARED AFTER TAKING HER SIGNED INFORMED CONSENT. HERE WE DISCUSS OUR PATIENT'S PROBLEMS THROUGH SERIES OF INPUTS FROM AVAILABLE GLOBAL ONLINE COMMUNITY EXPERTS WITH AN AIM TO SOLVE THOSE PATIENT'S CLINICAL PROBLEMS WITH COLLECTIVE CURRENT BEST EVIDENCE BASED INPUTS.
Sunday, May 19, 2024
PaJR CGM case report 80F Diabetes, hypertension, hypothyroidism 30 years, neuropathy 2 years Karnataka
Born March 1944
Hypothyroidism (TSH 100 in 1990)
Diabetes, Hypertension since 2000
Neuropathy with gait ataxia 2 years
Multiple UTIs and most recent on May 2024
Was on
1.Glimeperide 4 mg twice daily
2. AMTAS AT Amlodipine and Atenolol once daily
3. GLYCIPHAGE metformin 500 mg once daily
4. TRIKA alprazolam 0.25 once at bedtime
5. Thyroxine 100 mcg once daily
Till recently
HbA1c 8.55 on 6 May 2024
Started on CGM since 19/5/24 for stringent glucose control toward preventing UTI when unexpectedly found to have hypoglycemias since today after 4 mg of Glimeperide in the morning (which she has been regularly consuming since few years now)
Summary of PaJR transcripts in October 2024:
On CGM monitoring, the insights obtained for this particular patient was that she was having recurrent hypoglycemia and her glimiperide doses were well optimised to prevent the hypoglycemic episodes and currently the patient's sugar control till 28 August 2024 showed an impeccable Hba1c of 7.2
[9.29 am, 17/11/2025] PPM 1: [17/11, 09:20] Patient advocate:
Saturday's 11/15/25 test results:
GLUCOSE, POST PRANDIAL (PP), 2 HOURS, SODIUM FLUORIDE PLASMA (2HR) 216 mg/dL
70-140
HEXOKINASE
[17/11, 09:20] Patient advocate:
HBA1C (GLYCATED HEMOGLOBIN), WHOLE BLOOD EDTA, HBA1C, GLYCATED HEMOGLOBIN 8.2% HPLC
ESTIMATED AVERAGE GLUCOSE (eAG)
No comments:
Post a Comment